Sign Up Today and Learn More About Aignostics Stock
Invest in or calculate the value of your shares in Aignostics or other pre-IPO companies through EquityZen's platform.
Aignostics Stock
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.
About Aignostics Stock
Founded
2018
Industries
Software, Data and Analytics, Science and Engineering
Aignostics Press Mentions
Stay in the know about the latest news on Aignostics
Aignostics leads latest crop of digital health financings
pharmaphorum • Nov 11, 2024
Last week recap: More than 60 tech funding deals worth over €1B
tech • Nov 04, 2024
Aignostics: $34 Million (Series B) Raised To Turn Complex Pathology Data Into Transformative Insights
pulse2 • Nov 03, 2024
Financings for November 1, 2024
bioworld • Nov 02, 2024
Aignostics GmbH. (10/29/24). "Press Release: Aignostics Secures $34M Series B to Enhance Precision Medicine with AI". Berlin & New York, NY.
life-sciences-europe • Oct 31, 2024
Aignostics Management
Leadership team at Aignostics
Board Observer
Christian Leikert
Co-founder & CEO
Viktor Matyas
Join now and verify your accreditation status to gain access to:
- Aignostics current valuation
- Aignostics stock price
- Available deals in Aignostics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Aignostics stock?
Accredited investors can buy pre-IPO stock in companies like Aignostics through EquityZen funds. These investments are made available by existing Aignostics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aignostics stock?
Shareholders can sell their Aignostics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
